Physician profile
Armando L Oliver
NPI 1013904440
$250,663.05
in general payments reported to CMS, 2019-2025
20 companies · $94K in 2025
The $94K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,528 · 2020: $3,908 · 2021: $13K · 2022: $62K · 2023: $28K · 2024: $46K · 2025: $94K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $152K · Travel and Lodging: $7,236 · Food and Beverage: $5,692 · Consulting Fee: $2,700 · Gift: $40.59 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $152,355.00 |
| Travel and Lodging | $7,235.87 |
| Food and Beverage | $5,692.49 |
| Consulting Fee | $2,700.00 |
| Gift | $40.59 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $205,727.19 | 2020-2025 | Acthar |
| Abbvie INC. | $29,186.42 | 2022-2025 | |
| Allergan, INC. | $12,384.91 | 2019-2022 | |
| Apellis Pharmaceuticals, INC. | $750.00 | 2023 | Syfovre |
| Bausch & Lomb Americas INC. | $711.00 | 2022-2025 | Vyzulta, Xiidra, Miebo |
| Regeneron Healthcare Solutions, INC. | $485.87 | 2019-2025 | Eylea, Eylea Hd |
| Novartis Pharmaceuticals Corporation | $373.83 | 2019-2023 | |
| Genentech USA, INC. | $227.16 | 2021-2023 | Vabysmo |
| Alcon Puerto Rico INC | $149.48 | 2023-2025 | Clareon |
| Samsara Vision | $138.92 | 2025 | Implantable Miniature Telescope (Imt By Dr. Isaac Lipshitz) |
| Mallinckrodt Enterprises LLC | $106.67 | 2019 | |
| Ani Pharmaceuticals, INC. | $85.22 | 2025 | Iluvien, Purified Cortrophin Gel |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $68.53 | 2021 | |
| Alcon Vision LLC | $51.93 | 2024 | Clareon |
| Rhythm Pharmaceuticals, INC. | $49.80 | 2023 | Imcivree |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $49.47 | 2022 | |
| Genentech, INC. | $49.00 | 2023-2024 | Vabysmo |
| Alexion Pharmaceuticals, INC. | $27.52 | 2024 | |
| Alimera Sciences, INC. | $20.13 | 2023 | Iluvien |
| Amgen INC. | $20.00 | 2025 | Pavblu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armando Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.